417 related articles for article (PubMed ID: 20375988)
1. Hepatocyte growth factor signaling ameliorates podocyte injury and proteinuria.
Dai C; Saleem MA; Holzman LB; Mathieson P; Liu Y
Kidney Int; 2010 Jun; 77(11):962-73. PubMed ID: 20375988
[TBL] [Abstract][Full Text] [Related]
2. Preservations of nephrin and synaptopodin by recombinant hepatocyte growth factor in podocytes for the attenuations of foot process injury and albuminuria in nephritic mice.
Kato T; Mizuno S; Nakamura T
Nephrology (Carlton); 2011 Mar; 16(3):310-8. PubMed ID: 21342325
[TBL] [Abstract][Full Text] [Related]
3. Podocyte-specific NF-κB inhibition ameliorates proteinuria in adriamycin-induced nephropathy in mice.
Yamashita M; Yoshida T; Suzuki S; Homma K; Hayashi M
Clin Exp Nephrol; 2017 Feb; 21(1):16-26. PubMed ID: 27089875
[TBL] [Abstract][Full Text] [Related]
4. Non-canonical Wnt/calcium signaling is protective against podocyte injury and glomerulosclerosis.
Zhou D; Wang Y; Gui Y; Fu H; Zhou S; Wang Y; Bastacky SI; Stolz DB; Liu Y
Kidney Int; 2022 Jul; 102(1):96-107. PubMed ID: 35341792
[TBL] [Abstract][Full Text] [Related]
5. Melanocortin therapy ameliorates podocytopathy and proteinuria in experimental focal segmental glomerulosclerosis involving a podocyte specific non-MC1R-mediated melanocortinergic signaling.
Qiao Y; Wang P; Chang M; Chen B; Ge Y; Malhotra DK; Dworkin LD; Gong R
Clin Sci (Lond); 2020 Apr; 134(7):695-710. PubMed ID: 32167144
[TBL] [Abstract][Full Text] [Related]
6. Systemic administration of naked plasmid encoding HGF attenuates puromycin aminonucleoside-induced damage of murine glomerular podocytes.
Bu X; Zhou Y; Zhang H; Qiu W; Chen L; Cao H; Fang L; Wen P; Tan R; Yang J
Am J Physiol Renal Physiol; 2011 Oct; 301(4):F784-92. PubMed ID: 21775482
[TBL] [Abstract][Full Text] [Related]
7. Autophagy is activated to protect against podocyte injury in adriamycin-induced nephropathy.
Yi M; Zhang L; Liu Y; Livingston MJ; Chen JK; Nahman NS; Liu F; Dong Z
Am J Physiol Renal Physiol; 2017 Jul; 313(1):F74-F84. PubMed ID: 28404589
[TBL] [Abstract][Full Text] [Related]
8. Critical roles of PI3K/Akt/NF‑κB survival axis in angiotensin II‑induced podocyte injury.
Wang J; Fu D; Senouthai S; You Y
Mol Med Rep; 2019 Dec; 20(6):5134-5144. PubMed ID: 31638199
[TBL] [Abstract][Full Text] [Related]
9. Renin-angiotensin blockade resets podocyte epigenome through Kruppel-like Factor 4 and attenuates proteinuria.
Hayashi K; Sasamura H; Nakamura M; Sakamaki Y; Azegami T; Oguchi H; Tokuyama H; Wakino S; Hayashi K; Itoh H
Kidney Int; 2015 Oct; 88(4):745-53. PubMed ID: 26108068
[TBL] [Abstract][Full Text] [Related]
10. MYDGF attenuates podocyte injury and proteinuria by activating Akt/BAD signal pathway in mice with diabetic kidney disease.
He M; Li Y; Wang L; Guo B; Mei W; Zhu B; Zhang J; Ding Y; Meng B; Zhang L; Xiang L; Dong J; Liu M; Xiang L; Xiang G
Diabetologia; 2020 Sep; 63(9):1916-1931. PubMed ID: 32588068
[TBL] [Abstract][Full Text] [Related]
11. HGF alleviates high glucose-induced injury in podocytes by GSK3β inhibition and autophagy restoration.
Zhang C; Hou B; Yu S; Chen Q; Zhang N; Li H
Biochim Biophys Acta; 2016 Nov; 1863(11):2690-2699. PubMed ID: 27526674
[TBL] [Abstract][Full Text] [Related]
12. Combination of cilostazol and probucol protected podocytes from lipopolysaccharide-induced injury by both anti-inflammatory and anti-oxidative mechanisms.
He P; Kawamura H; Takemoto M; Maezawa Y; Ishikawa T; Ishibashi R; Sakamoto K; Shoji M; Hattori A; Yamaga M; Ide S; Ide K; Hayashi A; Tokuyama H; Kobayashi K; Yokote K
J Nephrol; 2017 Aug; 30(4):531-541. PubMed ID: 28005239
[TBL] [Abstract][Full Text] [Related]
13. Wnt/beta-catenin signaling promotes podocyte dysfunction and albuminuria.
Dai C; Stolz DB; Kiss LP; Monga SP; Holzman LB; Liu Y
J Am Soc Nephrol; 2009 Sep; 20(9):1997-2008. PubMed ID: 19628668
[TBL] [Abstract][Full Text] [Related]
14. IL-1 receptor signaling in podocytes limits susceptibility to glomerular damage.
Ren J; Lu X; Hall G; Privratsky JR; Robson MJ; Blakely RD; Crowley SD
Am J Physiol Renal Physiol; 2022 Feb; 322(2):F164-F174. PubMed ID: 34894725
[TBL] [Abstract][Full Text] [Related]
15. Activation of podocyte Notch mediates early Wt1 glomerulopathy.
Asfahani RI; Tahoun MM; Miller-Hodges EV; Bellerby J; Virasami AK; Sampson RD; Moulding D; Sebire NJ; Hohenstein P; Scambler PJ; Waters AM
Kidney Int; 2018 Apr; 93(4):903-920. PubMed ID: 29398135
[TBL] [Abstract][Full Text] [Related]
16. GIV/girdin links vascular endothelial growth factor signaling to Akt survival signaling in podocytes independent of nephrin.
Wang H; Misaki T; Taupin V; Eguchi A; Ghosh P; Farquhar MG
J Am Soc Nephrol; 2015 Feb; 26(2):314-27. PubMed ID: 25012178
[TBL] [Abstract][Full Text] [Related]
17. Notoginsenoside R1 ameliorates podocyte injury in rats with diabetic nephropathy by activating the PI3K/Akt signaling pathway.
Huang G; Lv J; Li T; Huai G; Li X; Xiang S; Wang L; Qin Z; Pang J; Zou B; Wang Y
Int J Mol Med; 2016 Oct; 38(4):1179-89. PubMed ID: 27571993
[TBL] [Abstract][Full Text] [Related]
18. Divergent roles of Smad3 and PI3-kinase in murine adriamycin nephropathy indicate distinct mechanisms of proteinuria and fibrogenesis.
Finer G; Schnaper HW; Kanwar YS; Liang X; Lin HY; Hayashida T
Kidney Int; 2012 Sep; 82(5):525-36. PubMed ID: 22534961
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor-α is renoprotective in doxorubicin-induced glomerular injury.
Zhou Y; Kong X; Zhao P; Yang H; Chen L; Miao J; Zhang X; Yang J; Ding J; Guan Y
Kidney Int; 2011 Jun; 79(12):1302-11. PubMed ID: 21368746
[TBL] [Abstract][Full Text] [Related]
20. Semaphorin3A-Inhibitor Ameliorates Doxorubicin-Induced Podocyte Injury.
Sang Y; Tsuji K; Inoue-Torii A; Fukushima K; Kitamura S; Wada J
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32521824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
